Forian Inc 2026年季度报告

FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the quarter ended March 31, 2026 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 Commission file number: 001-40146 FORIAN INC. (Exact name of registrant as specified in its charter) Registrant’s telephone number, including area code: (267) 225-6263 Securities registered pursuant to Section 12(b) of the Act: Name of Each Exchange OnWhich Registered Title of Each Class Common Stock, $0.001 Par Value PerShare The Nasdaq Stock Market LLC FORA Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of theSecurities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to filesuch reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically; every Interactive Data File required to besubmitted pursuant to Rule 405 of Regulation S-T (§232.0405 of this chapter) during the preceding 12 months (or for such shorterperiod that the registrant was required to submit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b 2 of the Exchange Act. Large accelerated filer☐Accelerated filer☐Non-accelerated filer☒Smaller reporting company☒Emerging growth company☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition periodfor complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b 2 of the Act). Yes☐No☒ As of May 14, 2026, there were 31,240,882 shares outstanding of the registrant’s common stock. Item 1.Financial StatementsCondensed Consolidated Balance Sheets as of March 31, 2026 (unaudited) and December 31, 20251Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2026 and 2025(unaudited)2Condensed Consolidated Statements of Stockholders' Equity for the Three Months Ended March 31, 2026 and2025 (unaudited)3Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025(unaudited)4Notes to Unaudited Condensed Consolidated Financial Statements5Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations21Item 3.Quantitative and Qualitative Disclosures About Market Risk31Item 4.Controls and Procedures31PART IIOTHER INFORMATION32Item 1.Legal Proceedings32Item 1A.Risk Factors33Item 2.Unregistered Sales of Equity Securities and Use of Proceeds33Item 3.Defaults Upon Senior Securities33Item 4.Mine Safety Disclosures33Item 5.Other Information33Item 6.Exhibits33Signatures34 FORIAN INC.CONDENSED CONSOLIDATED BALANCE SHEETSAS OF MARCH 31, 2026 AND 2025 LIABILITIES AND STOCKHOLDERS' EQUITY FORIAN INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONSFOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025(UNAUDITED) FORIAN INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWSFOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025(UNAUDITED) The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. FORIAN INC.NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Note 1BUSINESS ORGANIZATION AND NATURE OF OPERATIONS Forian Inc. (the “Company” or “Forian”) was incorporated in Delaware on October 15, 2020 as a wholly owned subsidiary ofForian LLC (f/k/a Medical Outcomes Research Analytics, LLC) (“MOR”) for the purpose of effecting the business combination withHelix Technologies, Inc. (“Helix”). Forian provides a unique suite of data management capabilities and proprietary information andanalytics solutions to optimize and measure operational, clinical and financial performance for customers within the healthcare and lifesciences and financial services industries. On January 8, 2026, at a special meeting of stockholders (the “Special Meeting”) of Forian, Inc., the stockholders of theCompany approved a proposal to redomicile through a statutory conversion (the “Redomiciliation”) the Company from a corporationorganized under the laws of the State of Delaware (the “Delaware Corporation”) to a corporation organized under the laws of the Stateof Maryland (the “Maryland Corporation”) by means of a plan of conversion (the “Plan of Conversion”) and adopted the resolutions ofthe board of directors of the Company approving the Redomiciliation. On October 3